Fitzgerald Kevin Joseph

EDGAR CIK 0001886431

Alnylam Pharmaceuticals, Inc. - ALNY

Officer
CSO & EVP, Head of Research
Direct Buys
0
$0
0 Shares
Direct Sells
8
($2.35) M
-9,552 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/04/2025
10b5-1
03/05/2025
Sell
-844 @ $241.15
($203,532) 13,501 (-5.88%) Direct
03/03/2025
10b5-1
03/05/2025
Sell
-1,911 @ $243.73
($465,772) 14,345 (-11.76%) Direct
02/28/2025
03/03/2025
Sell
-496 @ $241.69
($119,878) 12,385 (-3.85%) Direct
02/18/2025
10b5-1
02/18/2025
Sell
-1,440 @ $251.56
($362,243) 12,881 (-10.06%) Direct
02/14/2025
02/18/2025
Sell
-663 @ $255.21
($169,204) 14,321 (-4.42%) Direct
11/27/2024
10b5-1
11/27/2024
Sell
-1,531 @ $252.29
($386,261) 12,881 (-10.62%) Direct
11/26/2024
11/27/2024
Sell
-1,469 @ $250.98
($368,686) 14,412 (-9.25%) Direct
06/25/2024
06/26/2024
Sell
-1,198 @ $230.99
($276,731) 14,181 (-7.79%) Direct